Ukulethwa Kwezidakamizwa Okuhlosiwe Ezibhedlela Zomdlavuza

Ukulethwa Kwezidakamizwa Okuhlosiwe Ezibhedlela Zomdlavuza: Ukuthuthukisa Ukwelashwa Ngempumelelo Izinhlelo eziqondiwe zokulethwa kwezidakamizwa zishintsha ukwelashwa komdlavuza, zinikeza ukusebenza ngempumelelo kanye nemiphumela engemihle eyehlisiwe ezigulini. Lesi sihloko sihlola izindlela ezahlukahlukene ezisetshenziswa ku ukulethwa kwezidakamizwa okuhlosiwe kwezibhedlela zomdlavuza, ukuhlola izindlela zabo, izinzuzo, nezinselele. Sizocubungula izibonelo ezithile futhi sicabangele ikusasa lalo mkhakha obalulekile ku-oncology.

Ukuqonda Ukulethwa Kwezidakamizwa Okuhlosiwe

Kuyini Ukulethwa Kwezidakamizwa Okuhlosiwe?

Ngokungafani ne-chemotherapy yendabuko, esabalalisa izidakamizwa emzimbeni wonke, ukulethwa kwezidakamizwa okuhlosiwe kwezibhedlela zomdlavuza igxile ekuletheni ama-ejenti okwelapha ngqo kumaseli omdlavuza. Le ndlela inciphisa ukulimala kwezicubu ezinempilo, okuholela emiphumeleni engemihle embalwa kanye nemiphumela yokwelashwa ethuthukisiwe. Kusetshenziswa izindlela ezahlukahlukene ukuze kufezwe lokhu kulethwa okuhlosiwe, ngayinye enezici ezihlukile kanye nezicelo.

Izindlela Zokulethwa Kwezidakamizwa Okuhlosiwe

Izindlela eziningana zisiza ukulethwa kwezidakamizwa okuhlosiwe kwezibhedlela zomdlavuza. Lokhu kubandakanya:

• Ama-antibody-drug conjugates (ADCs): Amasosha omzimba abopha ngokuqondile kumaseli omdlavuza, ethwala umuthi onamathiselwe ngqo esimila.
• Ukulethwa kwezidakamizwa ze-Liposomal: Izidakamizwa zihlanganiswe ngaphakathi kwama-liposomes, abese eqondiswe kumangqamuzana omdlavuza esebenzisa ama-ligands athile noma amasosha omzimba.
• Ukulethwa kwezidakamizwa ze-Nanoparticle: Ama-nanoparticles angaklanywa ukuthwala izidakamizwa endaweni yesimila, okungenzeka asebenzise umphumela othuthukisiwe wokungena nokugcinwa (EPR).
• Ama-nanoparticles ahlosiwe: Lokhu kusebenzisa ukuguqulwa kwendawo okufana nama-ligand noma amasosha omzimba ukuze aqondise amaseli wesimila.

Izinhlobo Zezinhlelo Ezihlosiwe Zokulethwa Kwezidakamizwa

Ama-Antibody-Drug Conjugates (ADCs)

Ama-ADC ayisibonelo esivelele ukulethwa kwezidakamizwa okuhlosiwe kwezibhedlela zomdlavuza. Bahlanganisa ukucaciswa kwamasosha omzimba we-monoclonal namandla ezidakamizwa ze-cytotoxic. Le ndlela ithuthukisa ukusebenza kahle ngokuletha umuthi ngokuqondile kumaseli omdlavuza, kuyilapho konga izicubu ezinempilo. Isibonelo, i-trastuzumab emtansine (Kadcyla) iyi-ADC esetshenziselwa ukwelapha umdlavuza webele we-HER2-positive.¹

I-Liposomal Drug Delivery

Ama-Liposomes ahlanganisa umuthi, awuvikele ekuwohlokeni futhi akhulise isikhathi sokujikeleza kwawo egazini. Le pharmacokinetics ethuthukisiwe ivumela ukulethwa okuhlosiwe kumaseli wesimila ngokusebenzisa ama-ligands athile aqondiswe noma ukunqwabelana okungenzi lutho ngomphumela we-EPR. I-Doxorubicin liposomes (isb., i-Doxil) iyisibonelo esivunyelwe ngokomtholampilo.²

Izinzuzo kanye Nezinselele Zokulethwa Kwezidakamizwa Okuhlosiwe

Ikusasa Lokulethwa Kwezidakamizwa Okuhlosiwe Ezibhedlela Zomdlavuza

Ucwaningo luyaqhubeka nokucwenga nokwandisa amathuba okuthi ukulethwa kwezidakamizwa okuhlosiwe kwezibhedlela zomdlavuza. Intuthuko ku-nanotechnology, genomics, kanye ne-imaging iholela ekuthuthukisweni kwezinhlelo eziyinkimbinkimbi nezisebenza ngempumelelo. Ukuhlanganiswa kwemithi yomuntu siqu kanye nokusetshenziswa kwemithi yokwelapha ehlangene nakho kuvula indlela yemiphumela ethuthukisiwe yokwelashwa komdlavuza. Ukuze uthole ulwazi olwengeziwe mayelana nokwelashwa komdlavuza okuthuthukile kanye nocwaningo, vakashela ku I-Shandong Baofa Cancer Research Institute.

¹ I-FDA. (n.d.). I-Kadcyla (trastuzumab emtansine). Kuthathwe [https://www.fda.gov/drugs/informationondrugs/approveddrugs/ucm361642.htm](https://www.fda.gov/drugs/informationondrugs/approveddrugs/ucm361642.htm)

² I-FDA. (n.d.). I-DOXIL (umjovo we-doxorubicin HCl liposomal). Kubuyiswe ku-[https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020515](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo500)